Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Onconova's Public Debut: What You'll Want To Know
Seeking Alpha
Saturday, July 27, 2013 - 11:15am
tags:
Onconova, IPOs
Merrimack Progresses with MM-111
Yahoo/Zacks
Saturday, July 27, 2013 - 11:13am
tags:
Merrimack Pharmaceuticals, cancer, gastric cancer, esophageal cancer, gastroesophageal cancer
Amgen Announces 2013 Third Quarter Dividend
Yahoo/PR Newswire
Saturday, July 27, 2013 - 11:11am
tags:
Amgen
Theravance Narrows Loss
Yahoo/Zacks
Saturday, July 27, 2013 - 11:10am
tags:
Theravance, earnings
Vertex Says U.S. Places Partial Hold on Hepatitis Study
Bloomberg
Saturday, July 27, 2013 - 11:09am
tags:
Vertex Pharmaceuticals, VX-135, hepatitis, hepatitis C
Stemline: An Oncology Company, Not A Regenerative Cell Therapy Company
Seeking Alpha
Saturday, July 27, 2013 - 11:08am
tags:
Stemline
Vivus Sales Pace Continues Impressive Run - Why?
Seeking Alpha
Saturday, July 27, 2013 - 11:06am
tags:
Vivus, Qsymia, obesity, weight loss
Vivus Sales Pace Continues Impressive Run - Why?
Seeking Alpha
Saturday, July 27, 2013 - 11:06am
tags:
Vivus, Qsymia, obesity, weight loss
Wall Street Happy To Hum La AbbVie En Rose
Investopedia
Saturday, July 27, 2013 - 11:05am
tags:
AbbVie
Biotech Stocks Under Pressures, Focus On IPOs
Property Mentor Group
Friday, July 26, 2013 - 11:37am
tags:
IPOs, Sequenom, Invovio, Aeterna Zentaris, Sarepta, InterMune, Cryolife, BiogenIdec, Boston Scientific, Varian Medical, Warner Chilcott
Stem cell pioneer's biotech startup raises $46M in IPO
Fierce Biotech
Friday, July 26, 2013 - 11:34am
tags:
IPOs, stem cells, Cellular Dynamics
GlaxoSmithKline, Biogen Idec strike antibody deals with biotech startup Adimab
Fierce Biotech
Friday, July 26, 2013 - 11:33am
tags:
Adimab, GSK, BiogenIdec, antibody discovery
3 Things You Need to Know From Celgene's Q2 Earnings
Motley Fool
Friday, July 26, 2013 - 11:30am
tags:
earnings, Celgene
Europe backs new dual-action Novartis lung drug
Reuters
Friday, July 26, 2013 - 11:29am
tags:
Europe, Novartis, Ultibro Breezhaler
Arena's Belviq Continues Sales Traction
Seeking Alpha
Friday, July 26, 2013 - 11:27am
tags:
Belviq, Eisai, Arena Pharmaceuticals, obesity
Questcor Pharmaceuticals Earnings Up Next
Motley Fool
Friday, July 26, 2013 - 11:27am
tags:
Questcor, earnings
As Healthcare Demand Rises, So Will This Company's Profits
Motley Fool
Friday, July 26, 2013 - 11:26am
tags:
Pfizer
FDA limits use of J&J's Nizoral antifungal drug on safety concerns
Reuters
Friday, July 26, 2013 - 11:25am
tags:
FDA, JNJ, Nizoral, antifungals
FDA OK for Forest/Pierre Fabre antidepressant
Pharma Times, UK
Friday, July 26, 2013 - 9:09am
tags:
FDA, Forest Labs, Pierre Fabre, antidepressants, Fetzima
Cubist Pharmaceuticals: Doomsday Preparation Update
Seeking Alpha
Friday, July 26, 2013 - 9:07am
tags:
Cubist Pharmaceuticals, Cubicin, generics, antiobiotics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.